Cargando...
(18)F-fluciclovine PET-CT and (68)Ga-PSMA-11 PET-CT in patients with early biochemical recurrence after prostatectomy: a prospective, single-centre, single-arm, comparative imaging trial
BACKGROUND: National Comprehensive Cancer Network guidelines consider (18)F-fluciclovine PET-CT for prostate cancer biochemical recurrence localisation after radical prostatectomy, whereas European Association of Urology guidelines recommend prostate-specific membrane antigen (PSMA) PET-CT. To the b...
Guardado en:
| Publicado en: | Lancet Oncol |
|---|---|
| Autores principales: | , , , , , , , , , , , , , , , , , , , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
2019
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7469487/ https://ncbi.nlm.nih.gov/pubmed/31375469 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/S1470-2045(19)30415-2 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|